Nuo Therapeutics ( (AURX) ) has released a notification of late filing.
Nuo Therapeutics, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to the company’s involvement in negotiating a commercial agreement, which required significant management attention and impacted their ability to complete the report on time. The company plans to file the report by April 1, 2025. Despite the delay, Nuo Therapeutics does not anticipate any significant changes in its financial results compared to the previous year. The company continues to express concerns about its ability to continue as a going concern. The notification was signed by David E. Jorden, the Chief Executive and Financial Officer, indicating ongoing compliance efforts.
More about Nuo Therapeutics
YTD Price Performance: -13.67%
Average Trading Volume: 3,706
Technical Sentiment Signal: Sell
Current Market Cap: $62.91M
For detailed information about AURX stock, go to TipRanks’ Stock Analysis page.